Federal award
ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH
W81K0225FA115
Contract
Obligated and Ceiling
- Obligated (net)
- $232,790.00
- Ceiling (potential value, not spending)
- $165,764.00
- Current value
- $165,764.00
- Gross positive obligations
- $232,790.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH · JNSJRDQQH2J6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ORTHO-CLINICAL DIAGNOSTICS SINGAPORE PTE. LTD. KOREA BRANCH · JNSJRDQQH2J6
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0225FA115
- Parent vehicle (IDV PIID)
- W81K0225DA003
- Award type code
- C
- Actions
- 6 · Sep 9, 2025 to Jun 2, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 2, 2026 | FY2026 | P00005 | M | $0.00 | — |
| May 20, 2026 | FY2026 | P00004 | M | $0.00 | — |
| Apr 6, 2026 | FY2026 | P00003 | M | $0.00 | — |
| Dec 23, 2025 | FY2026 | P00002 | C | $232,790.00 | — |
| Dec 16, 2025 | FY2026 | P00001 | M | $0.00 | — |
| Sep 9, 2025 | FY2025 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.